Details for New Drug Application (NDA): 020748
✉ Email this page to a colleague
The generic ingredient in DIFFERIN is adapalene. There are twelve drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the adapalene profile page.
Summary for 020748
Tradename: | DIFFERIN |
Applicant: | Galderma Labs Lp |
Ingredient: | adapalene |
Patents: | 0 |
Suppliers and Packaging for NDA: 020748
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFFERIN | adapalene | CREAM;TOPICAL | 020748 | NDA | GALDERMA LABORATORIES, L.P | 0299-5915 | 0299-5915-45 | 1 TUBE in 1 CARTON (0299-5915-45) / 45 g in 1 TUBE |
DIFFERIN | adapalene | CREAM;TOPICAL | 020748 | NDA AUTHORIZED GENERIC | Padagis Israel Pharmaceuticals Ltd | 45802-453 | 45802-453-84 | 1 TUBE in 1 CARTON (45802-453-84) / 45 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | May 26, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020748
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galderma Labs Lp | DIFFERIN | adapalene | CREAM;TOPICAL | 020748-001 | May 26, 2000 | ⤷ Subscribe | ⤷ Subscribe |
Galderma Labs Lp | DIFFERIN | adapalene | CREAM;TOPICAL | 020748-001 | May 26, 2000 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription